Navigation Links
Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
Date:6/18/2008

ration. Dr. Katz served on the executive committee of the Optic Neuritis Treatment Trial, and has been an active participant and principle investigator of many multi-centre clinical trials.

Dr. Katz currently serves as Clinical Professor of Ophthalmology at New York University School of Medicine as well as at the Weill Medical College of Cornell University. Dr. Katz served as a fellow at Harvard University in Boston, the National Institutes of Health, The National Hospital at Queen's Square in London, and the University of California at San Francisco after completing residencies in Neurology at Harvard Medical School and in Ophthalmology at Tufts-New England Medical Center. He received his MD with honors from the Case Western Reserve University School of Medicine and his AB, magna cum laude, from Colgate University. He is the author of several hundred publications, and the recipient of over two dozen major research grants.

About Danube Pharmaceuticals, Inc.

Danube is a biopharmaceutical company dedicated to the research and development of treatments for diseases of the eye. Danube's lead compound DNB-001, is a small molecule for the treatment of glaucoma available in both oral and topical formulation. In preclinical studies DNB-001 has been shown through novel mechanisms of action to both lower intraocular pressure (IOP) and to provide direct neuroprotective benefits to the optic nerve and its retinal ganglion cells, providing a dual approach to glaucoma therapy not provided by any currently marketed product. DNB-001 has been tested in a Phase I clinical trial in Europe and is currently being studied in a Phase II clinical trial in Europe. For more information on Danube please visit http://www.danubepharma.com .

This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from antic
'/>"/>

SOURCE Danube Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barretts Esophagus
2. Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
3. Netsmarts Kevin Scalia Named Chair of the Software and Technology Vendors Association
4. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
5. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
6. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
7. Black Box Network Services, ABTECH, Verizon Business and Wyle Named Top Siemens Reseller Partners
8. BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards
9. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
10. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
11. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Protocol Networks brings independent technology consulting to ... independent consultants, Protocol Networks has recently announced its expansion ... years, his company has attracted several clients in The ... well as others. With the success of these engagements, ...
(Date:1/22/2015)... 2015 zFlo Motion , a US ... an exciting product from a new partner. STT-Systems ... the past 15 years, with offerings in the optical-motion capture, ... IMU system (inertial measurement unit), iSen, is opening eyes around ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, ... Sequenom, Inc. (NASDAQ: SQNM ), the ... agreement for next generation noninvasive prenatal tests (NIPT). ... interpretation technology, called Mantis™, to advance analysis of ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 23D Motion Capture Just Got Easy 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... 21, 2010 The Pharmaceuticals practice,at MarketsandMarkets is pleased to announce a ... , , ... Calorie/Diet Beverages Market (2010,-2015)Market Report. Early buyers will receive 10% customization of reports, ... ...
... ... today announced an agreement under which Therapure will provide manufacturing ... Israel with an executive management team based in Woburn, MA. Under ... clinical manufacturing for one of ProChon’s products, which may be used ...
... Minnesota-led researchers has cleared a major hurdle in the drive ... as high as current levels, which rarely exceed 30 percent. ... from semiconductors in solar cells can be captured and transferred ... for solar cell researchers seeking to build cheaper, more efficient ...
Cached Biology Technology:World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets 2World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets 3Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd. 2University of Minnesota researchers clear major hurdle in road to high-efficiency solar cells 2
(Date:1/22/2015)... WINSTON-SALEM, N.C. , Jan. 16, 2015  A man-made ... working memory and other mental capabilities in adults with ... a pilot study led by researchers at Wake Forest ... 60 adults diagnosed with amnesic mild cognitive impairment (MCI) ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... of the "Global Wearable Technologies Market and ... Overview, Trends and Forecast 2014-2020" report to ... are smart devices that can be worn on ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... the "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight ... watermarking and fingerprinting markets. Watermarking aims to control ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2
... at UC Santa Barbara have discovered a caste of ... fluke species that invades the California horn snail. The ... the Proceedings of the Royal Society B . ... killer morphs defending the colony," said Armand M. Kuris, ...
... Menachem Shoham, PhD, associate professor and researcher in ... University School of Medicine, has identified new anti-pathogenic drugs ... Aureus (MRSA) harmless by preventing the production of toxins ... a growing public health problem causing 20,000 deaths per ...
... the support of an $11.8 million, five-year federal grant, ... are developing a quick-dissolving vaginal film containing a powerful ... they plan to begin testing it locally within a ... deliver breath fresheners, could have several advantages over vaginal ...
Cached Biology News:'Warrior worms' discovered in snails; UCSB scientists see possible biomedical applications 2Case Western Reserve researcher discovers new 'anti-pathogenic' drugs to treat MRSA 2Pitt gets $11.8 million to develop microbicide films for HIV prevention 2
Recombinant Mouse MMP-9, CF...
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Cyan Standard is 7-hydroxy-4-trifluoromethylcoumarin...
... High Sensitivity Freezing Point Osmometer for 10 L sample. Ideal for small volume applications, including pediatric, ... Ready to run in less than 3 minutes after turn-on. ... ... ...
Biology Products: